美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA078690"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
47335-188-08 47335-188 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 250 mg/1 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-188-08)
47335-188-18 47335-188 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 250 mg/1 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-188-18)
47335-188-83 47335-188 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 250 mg/1 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-188-83)
47335-188-88 47335-188 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 250 mg/1 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-188-88)
47335-187-08 47335-187 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-187-08)
47335-187-18 47335-187 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-187-18)
47335-187-83 47335-187 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-187-83)
47335-187-88 47335-187 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-187-88)
47335-186-08 47335-186 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 10 mg/1; 100 mg/1 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-08)
47335-186-18 47335-186 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 10 mg/1; 100 mg/1 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-18)
47335-186-83 47335-186 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 10 mg/1; 100 mg/1 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-83)
47335-186-88 47335-186 HUMAN PRESCRIPTION DRUG CARBIDOPA AND LEVODOPA CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING ORAL 20141215 N/A ANDA ANDA078690 Sun Pharmaceutical Industries, Inc. CARBIDOPA; LEVODOPA 10 mg/1; 100 mg/1 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-88)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase